Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRM-151 for scarring after glaucoma filtration surgery
NCT01064817Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2010
- Primary completion
- Apr 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 4
01
Overview
A Phase 2 trial of zinpentraxin alfa in Glaucoma, sponsored by Roche. Started Jun 2010; status: completed.
02
Drugs
zinpentraxin alfa
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT01064817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064817.